Synthesis, characterization, and application of 2-((3-(chloromethyl)-benzoyl)oxy)benzoic acid: A review

Tjahjono, Yudy, Caroline, Caroline, Foe, Kuncoro, Karnati, Srikanth, Ergün, Süleyman, Esar, . Senny Yesery, Wijaya, Hendy, Hadinugroho, Wuryanto, Kusindarta,, Dwi Liliek and Wihadmadyatamib, Hevi (2023) Synthesis, characterization, and application of 2-((3-(chloromethyl)-benzoyl)oxy)benzoic acid: A review. ACS Omega, 8 (1). pp. 42-47. ISSN 24701343

[thumbnail of Synthesis, characterization, and application of 2-((3-(chloromethyl)-benzoyl)oxy)benzoic acid: A review]
Preview
Text (Synthesis, characterization, and application of 2-((3-(chloromethyl)-benzoyl)oxy)benzoic acid: A review)
16-Synthesis_characterization_.pdf

Download (3MB) | Preview

Abstract

Salicylic acid (SA) derivate is well-known for its anti-inflammatory and analgesic activity through cyclooxygenase (COX)-inhibition. Previous studies pointed toward gastric toxicity induced by most salicylic acid derivative compounds, particularly acetylsalicylic acid (ASA). Despite the adverse effect, ASA is still used due to price affordability and additional advantages in preventing platelet aggregation. Recently, a novel salicylic acid derivative called 2-((3 (chloromethyl)benzoyl)oxy)benzoic acid(3-CHCl) was introduced as a potential alternative compound to substitute ASA. Preliminary assessment results of COX-2 specificity, toxicity profile, analgesic, anti-inflammatory, and antiplatelet activity have made 3-CH2Cl a promising compound for “new” drug development. This review focuses on the discovery, potential activity, and benefits of 3-CH2 Cl and the possible molecular mechanisms of its regulations in health and disease. Thus, this review may prove to be beneficial for the utilization of 3-CH2 Cl as a potential alternative drug to substitute ASA.

Item Type: Article
Subjects: Pharmacy
Divisions: Journal Publication
Depositing User: F.X. Hadi
Date Deposited: 01 Oct 2025 06:50
Last Modified: 01 Oct 2025 06:50
URI: https://repositori.ukwms.ac.id/id/eprint/44562

Actions (login required)

View Item View Item